Trial Profile

Treatment of Chronic Delta Hepatitis With Lonafarnib.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 15 Sep 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Lonafarnib (Primary)
Indications Hepatitis D
Focus Proof of concept; Therapeutic Use

Most Recent Events

17 Apr 2016 Pharmacokinetic, pharmacodynamics and viral kinetic results presented at The International Liver Congress™ 2016.
20 Jul 2015 Results published in an Eiger BioPharmaceuticals media
20 Jul 2015 According to an Eiger BioPharmaceuticals media release, data from this study were published in The Lancet Infectious Diseases.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com